Chuck Sidebottom , Director, Corporate Standards at Medtronic and Dave Osborn, Manager, International Standards at Philips, join Pharma IQ to discuss the current controversy over the application of risk management under the European medical device Directives, how the expectations for risk management have changed, how EN/ISO 14971 has been revised to deal with these expectations and how manufacturers and notified bodies are reacting to these revisions, which are causing a degree of confusion.
|
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |